MENU
BIOVF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Swedish Orphan Biovitrum AB (BIOVF) Ownership - Who owns Swedish Orphan Biovitrum AB?
Profile
Industry
N/A
Address
Tomtebodavagen 23 A
Phone
+46 86972000
Employees
1600
Web
https://www.sobi.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
5.81B
P/E Ratio
19.92
Total Cash
790M
Projected Growth
1.16
Total Debt
28.18B
Revenue
20.1B
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash/Share
2.66
Total Debt/Equity
N/A
Revenue/Share
6.37 USD as % of share price
Fundamentals
BIOVF
Capitalization
5.81B
P/E Ratio
19.92
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash
790M
Total Cash/Share
2.66
Total Debt
28.2B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.16
Revenue/Share (as % of the share price)
6.37%
Revenue
20.1B
ROE
N/A
Book Value
28.4B
P/B Ratio
2.18
Cash Flow
N/A
Earnings
10.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
171M
Current Ratio
0.59
Current Revenue Per Employee
2717233.80
Dividends Per Share - Security
N/A
EBITDA
6.96B
Float
N/A
Float - Current
N/A
Gross Income Margin
71.84
Revenue To Assets
5.03
Shares Held By Institutions
7.71B
Shares Outstanding - Current
297M
Total Liabilities
47.4B
Total Volume MTD
N/A
Value
-1
Gain YTD
9.029
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
N/A
Address
Tomtebodavagen 23 A
Phone
+46 86972000
Employees
1600
Web
https://www.sobi.com